Search results for "1006"

showing 10 items of 45 documents

RISK OF CARDIOVASCULAR DISEASE MORBIDITY AND MORTALITY IN FRAIL AND PRE-FRAIL OLDER ADULTS:RESULTS FROM A META-ANALYSIS AND EXPLORATORY META-REGRESSI…

2017

Frailty is common and associated with poorer outcomes in the elderly, but its role as potential cardiovascular disease (CVD) risk factor requires clarification. We thus aimed to meta-analytically evaluate the evidence of frailty and pre-frailty as risk factors for CVD. Two reviewers selected all studies comparing data about CVD prevalence or incidence rates between frail/pre-frail vs. robust. The association between frailty status and CVD in cross-sectional studies was explored by calculating and pooling crude and adjusted odds ratios (ORs)+/- 95% confidence intervals (CIs); the data from longitudinal studies were pooled using the adjusted hazard ratios (HRs). Eighteen cohorts with a total …

GerontologyAging1303 Biochemistry030204 cardiovascular system & hematologyBiochemistry0302 clinical medicineRisk Factorscardiovascular diseasePrevalenceMedicine030212 general & internal medicineCardiovascular disease; Frailty; Meta-analysis; Aged; Frail Elderly; Humans; Prevalence; Risk Assessment; Risk Factors; Cardiovascular Diseases; Biotechnology; Biochemistry; Aging; Molecular Biology; NeurologyOXIDATIVE STRESSProspective cohort studyELDERLY-PATIENTSPOPULATIONeducation.field_of_studyFrailtyHazard ratioMENASSOCIATION16. Peace & justiceCardiovascular disease3. Good healthMIDLIFE OBESITYNeurologyCardiovascular DiseasesMeta-analysis1305 BiotechnologyRisk assessmentCardiovascular disease; Frailty; Meta-analysis; Aged; Frail Elderly; Humans; Prevalence; Risk Assessment; Risk Factors; Cardiovascular DiseasesBiotechnologymedicine.medical_specialtyWOMENS-HEALTHFrail ElderlyPopulationCardiovascular disease; Frailty; Meta-analysis; Biotechnology; Biochemistry; Aging; Molecular Biology; Neurology610 Medicine & healthfrailtyFrailty Cardiovascular disease Meta-analysisRisk AssessmentArticle03 medical and health sciences1302 AgingInternal medicine1312 Molecular BiologyHumansCORONARY-HEART-DISEASERisk factorFrailty cardiovascular disease meta-analysiseducationMolecular BiologyAgedbusiness.industryAGE FRAILTYOdds ratio10060 Epidemiology Biostatistics and Prevention Institute (EBPI)Confidence intervalmeta-analysisMeta-analysis3121 General medicine internal medicine and other clinical medicine2808 NeurologyFOLLOW-UPbusiness
researchProduct

Dianthus superbus as a critically endangered species in Latvia: evaluation of its growth conditions and conservation possibilities

2021

Abstract Dianthus superbus is one of the most endangered species in Latvia and is on the verge of local extinction. Therefore, the aim of this study was to inventory previously identified populations of D. superbus in Latvia and to develop activities to conserve this species in accordance with the results obtained in situ. Expeditions on 18 previously documented locations, according to the data of Nature Conservation Agency, revealed only three existing D. superbus localities in Latvia with a significant number of specimens located in the Latgale region near Silenieki. In 2020, for the first time, two more new D. superbus localities were found in the vicinity of these three approved locatio…

AcademicSubjects/SCI01210habitat characteristics in situRange (biology)Endangered speciesDianthus superbusPlant ScienceConservation optionsBiologybiology.organism_classificationAobpla/1006HorticultureCritically endangeredAobpla/1059GerminationLocal extinctionseed viability and germinationShootStudiesBotanical gardensoil agrochemical analysisAobpla/1025AoB PLANTS
researchProduct

Observational constraints on the modelling of SN 1006

2011

supernova remnantsISM: individual: SN 1006radiation mechanisms: non-thermalacceleration of particlecosmic ray
researchProduct

The shape of the cutoff in the synchrotron emission of SN 1006 observed with XMM-Newton

2013

Synchrotron X-ray emission from the rims of young supernova remnants allows us to study the high-energy tail of the electrons accelerated at the shock front. The analysis of X-ray spectra can provide information on the physical mechanisms that limit the energy achieved by the electrons in the acceleration process. We aim at verifying whether the maximum electron energy in SN 1006 is limited by synchrotron losses and at obtaining information on the shape of the cutoff in the X-ray synchrotron emission. We analyzed the deep observations of the XMM-Newton SN 1006 Large Program. We performed spatially resolved spectral analysis of a set of small regions in the nonthermal limbs and studied the X…

Astrophysics::High Energy Astrophysical PhenomenaFOS: Physical sciencesISM: individual objects: SN 1006AstrophysicsElectron01 natural sciencesSpectral linelaw.inventionMomentumAccelerationlaw0103 physical sciencesRadiative transferCutoff010306 general physics010303 astronomy & astrophysicsISM: supernova remnantAstrophysics::Galaxy AstrophysicsISM: supernova remnantsHigh Energy Astrophysical Phenomena (astro-ph.HE)PhysicsAstronomy and AstrophysicsAstronomy and AstrophysicX-rays: ISMSynchrotronSupernovaSpace and Planetary ScienceAstrophysics - High Energy Astrophysical Phenomena[PHYS.ASTR]Physics [physics]/Astrophysics [astro-ph]
researchProduct

Association of prestroke metformin use, stroke severity, and thrombolysis outcome

2020

ObjectiveTo evaluate whether pretreatment with metformin (MET) is associated with less stroke severity and better outcome after IV thrombolysis (IVT), we analyzed a cohort of 1,919 patients with stroke with type 2 diabetes mellitus in a multicenter exploratory analysis.MethodsData from patients with diabetes and ischemic stroke treated with IVT were collected within the European Thrombolysis in Ischemic Stroke Patients (TRISP) collaboration. We applied propensity score matching (PSM) to obtain balanced baseline characteristics of patients treated with and without MET.ResultsOf 1,919 patients with stroke with type 2 diabetes who underwent IVT, 757 (39%) had received MET before stroke (MET+),…

Malemedicine.medical_specialtymedicine.medical_treatment610 Medicine & health030204 cardiovascular system & hematology03 medical and health sciences0302 clinical medicineFibrinolytic AgentsModified Rankin ScaleInternal medicineDiabetes mellitusEpidemiologymedicineHumansHypoglycemic AgentsThrombolytic Therapycardiovascular diseases10064 Neuroscience Center ZurichStrokeAgedRetrospective Studiesbusiness.industryRecovery of Function10060 Epidemiology Biostatistics and Prevention Institute (EBPI)ThrombolysisMiddle Agedmedicine.diseaseMetformin10040 Clinic for Neurology3. Good healthMetforminStroke2728 Neurology (clinical)Diabetes Mellitus Type 2Propensity score matchingCohortFemaleNeurology (clinical)business030217 neurology & neurosurgerymedicine.drugNeurology
researchProduct

Changing geographical patterns and trends in cancer incidence in children and adolescents in Europe, 1991–2010 (Automated Childhood Cancer Informatio…

2018

List of ACCIS contributors = Monika Hackl, Anna Zborovskaya, Nadya Dimitrova, Zdravka Valerianova, Ladislav Dušek, Margit Mägi, Alain Monnereau, Jacqueline Clavel, Michel Velten, Anne-Valérie Guizard, Véronique Bouvier, Xavier Troussard, Anne-Sophie Woronoff, Emilie Marrer, Brigitte Trétarre, Marc Colonna, Olivier Ganry, Pascale Grosclaude, Berndt Holleczek, Zsuzsanna Jakab, Laufey Tryggvadóttir, Lucia Mangone, Franco Merletti, Stefano Ferretti, Bianca Caruso, Maria Michiara, Rosario Tumino, Fabio Falcini, Roberto Zanetti, Giovanna Tagliabue, Otto Visser, Giske Ursin, Ryszard Mężyk, Kamila Kepska, José Laranja Pontes, Maja Primic Žakelj, Rafael Fernández-Delgado, Marisa L Vicente Raneda, En…

MaleCàncer en els infantsTime FactorsCancer in children0302 clinical medicineRisk FactorsNeoplasms030212 general & internal medicineRegistriesAge of OnsetChildmedia_commoneducation.field_of_studyCancer in adolescenceIncidence (epidemiology)Incidence3. Good healthEuropeOncology030220 oncology & carcinogenesisRegional studiesChild PreschoolFemale2730 OncologyAdolescentPopulationChildhood cancerSocio-culturale610 Medicine & healthRisk AssessmentArticle03 medical and health sciencesYoung AdultAge DistributionSDG 3 - Good Health and Well-beingmedicinemedia_common.cataloged_instanceHumansCàncer en els adolescentsEuropean unioneducationbusiness.industryInfant NewbornCancerInfantHealth Status Disparities10060 Epidemiology Biostatistics and Prevention Institute (EBPI)medicine.diseasePopulation based studyCancer incidencebusinessDemography
researchProduct

Modeling the shock-cloud interaction in SN 1006: unveiling the origin of nonthermal X-ray and gamma-ray emission

2016

The supernova remnant SN 1006 is a source of high-energy particles and its southwestern limb is interacting with a dense ambient cloud, thus being a promising region for gamma-ray hadronic emission. We aim at describing the physics and the nonthermal emission associated with the shock-cloud interaction to derive the physical parameters of the cloud (poorly constrained by the data analysis), to ascertain the origin of the observed spatial variations in the spectral properties of the X-ray synchrotron emission, and to predict spectral and morphological features of the resulting gamma-ray emission. We performed 3-D magnetohydrodynamic simulations modeling the evolution of SN 1006 and its inter…

AstrofísicaProper motionMagnetohydrodynamics (MHD)[ PHYS.ASTR ] Physics [physics]/Astrophysics [astro-ph]Astrophysics::High Energy Astrophysical PhenomenaHadronFOS: Physical sciencesContext (language use)AstrophysicsISM: individual objects: SN 100601 natural sciencesISM: cloudslaw.inventionSettore FIS/05 - Astronomia E AstrofisicalawISM: cloud0103 physical sciencesMagnetohydrodynamic driveSupernova remnant010303 astronomy & astrophysicsISM: supernova remnantAstrophysics::Galaxy Astrophysicsacceleration of particlesISM: supernova remnantsPhysicsHigh Energy Astrophysical Phenomena (astro-ph.HE)010308 nuclear & particles physicsclouds; ISM: individual objects: SN 1006; ISM: supernova remnants; Magnetohydrodynamics (MHD); X-rays: ISM; Astronomy and Astrophysics; Space and Planetary Science [Acceleration of particles; ISM]X-rayAstronomy and AstrophysicsAstronomy and AstrophysicAcceleration of particleSynchrotronX-rays: ISMShock (mechanics)Astronomía13. Climate actionSpace and Planetary ScienceAstrophysics - High Energy Astrophysical Phenomena[PHYS.ASTR]Physics [physics]/Astrophysics [astro-ph]
researchProduct

Decreased Fibrogenesis After Treatment with Pirfenidone in a Newly Developed Mouse Model of Intestinal Fibrosis

2016

BACKGROUND Fibrosis as a common problem in patients with Crohn's disease is a result of an imbalance toward excessive tissue repair. At present, there is no specific treatment option. Pirfenidone is approved for the treatment of idiopathic pulmonary fibrosis with both antifibrotic and anti-inflammatory effects. We subsequently investigated the impact of pirfenidone treatment on development of fibrosis in a new mouse model of intestinal fibrosis. METHODS Small bowel resections from donor mice were transplanted subcutaneously into the neck of recipients. Animals received either pirfenidone (100 mg/kg, three times daily, orally) or vehicle. RESULTS After administration of pirfenidone, a signif…

0301 basic medicinemedicine.medical_specialtyPyridonesBlotting Western610 Medicine & healthGastroenterologyImmunoenzyme TechniquesMice03 medical and health sciencesIdiopathic pulmonary fibrosis0302 clinical medicineTransforming Growth Factor betaFibrosis10049 Institute of Pathology and Molecular PathologyInternal medicinemedicineAnimalsImmunology and Allergy2715 GastroenterologyCell ProliferationMice Inbred BALB CbiologyCell growthbusiness.industryAnti-Inflammatory Agents Non-SteroidalGastroenterologyPirfenidoneTransforming growth factor betamedicine.diseaseFibrosisMice Inbred C57BLTransplantationBlotDisease Models AnimalIntestinal Diseases10219 Clinic for Gastroenterology and Hepatology030104 developmental biology2723 Immunology and Allergybiology.proteinFemale030211 gastroenterology & hepatologyCollagen10069 Clinic of Cranio-Maxillofacial SurgerybusinessAfter treatmentmedicine.drugInflammatory Bowel Diseases
researchProduct

The loss-limited electron energy in SN 1006: effects of the shock velocity and of the diffusion process

2013

The spectral shape of the synchrotron X-ray emission from SN 1006 reveals the fundamental role played by radiative losses in shaping the high-energy tail of the electron spectrum. We analyze data from the XMM-Newton SN 1006 Large Program and confirm that in both nonthermal limbs the loss-limited model correctly describes the observed spectra. We study the physical origin of the observed variations of the synchrotron cutoff energy across the shell. We investigate the role played by the shock velocity and by the electron gyrofactor. We found that the cutoff energy of the syncrotron X-ray emission reaches its maximum value in regions where the shock has experienced its highest average speed. T…

High Energy Astrophysical Phenomena (astro-ph.HE)Space and Planetary ScienceAstrophysics::High Energy Astrophysical PhenomenaISM: individual object: (SN 1006)FOS: Physical sciencesAstronomy and AstrophysicAstrophysics - High Energy Astrophysical PhenomenaISM: supernova remnantX-rays: ISM
researchProduct

The outer shock of SN1006

2008

SNR: SN 1006
researchProduct